We serve Chemical Name:5-Chloro-3,4-pyridinediamine CAS:929074-42-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Chloro-3,4-pyridinediamine
CAS.NO:929074-42-0
Synonyms:5-Chloropyridine-3,4-diamine;3,4-Diamino-5-chloropyridine;3,4-Pyridinediamine, 5-chloro-;5-Chloro-3,4-diaminopyridine;5-Chloro-3,4-pyridinediamine
Molecular Formula:C5H6ClN3
Molecular Weight:143.574
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:359.1±37.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.685
PSA:64.93000
Exact Mass:143.025024
LogP:1.42
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-Chloropyridine-3,4-diamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Chloro-3,4-pyridinediamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,4-Diamino-5-chloropyridine Use and application,5-Chloro-3,4-diaminopyridine technical grade,usp/ep/jp grade.
Related News: Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. 5-Chloro-3,4-pyridinediamine manufacturer Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. 5-Chloro-3,4-pyridinediamine supplier Saudi Arabia��s state airline and Oman also suspended flights to China on Sunday in reaction to the coronavirus epidemic, according to Reuters. 5-Chloro-3,4-pyridinediamine vendor Lilly did show much more conclusively that donanemab, which zeroes in on amyloid plaques, does reduce levels of the aggregates of misfolded proteins in the brain. This is what Biogen also showed with Aduhelm, and it turned out this week to be enough for a full FDA approval, hence the stock bump for Lilly. 5-Chloro-3,4-pyridinediamine factory Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection.
